We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+5.84%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$36.3B
AUM Growth
–
Cap. Flow
+$35.7B
Cap. Flow
% of AUM
98.28%
Top 10 Holdings %
Top 10 Hldgs %
20.26%
Holding
696
New
696
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$896M |
| 2 |
Pfizer
PFE
|
+$883M |
| 3 |
Citigroup
C
|
+$777M |
| 4 |
ExxonMobil
XOM
|
+$768M |
| 5 |
Wells Fargo
WFC
|
+$755M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.9% |
| 2 | Healthcare | 17.42% |
| 3 | Technology | 11.83% |
| 4 | Energy | 10.76% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
JPMorgan Chase
JPM
$953B
| $930M | 2.56% |
+17,616,367
| New | +$896M |
|
|
2
Pfizer
PFE
$162B
| $849M | 2.34% |
+31,950,482
| New | +$883M |
|
|
3
Wells Fargo
WFC
$272B
| $799M | 2.2% |
+19,370,146
| New | +$755M |
|
|
4
Citigroup
C
$231B
| $775M | 2.13% |
+16,155,363
| New | +$777M |
|
|
5
ExxonMobil
XOM
$656B
| $771M | 2.12% |
+8,533,700
| New | +$768M |
|
6
Occidental Petroleum
OXY
$60B
| $709M | 1.95% |
+8,290,430
| New | +$700M |
|
7
Berkshire Hathaway Class B
BRK.B
$1.08T
| $672M | 1.85% |
+6,004,190
| New | +$661M |
|
8
Johnson & Johnson
JNJ
$663B
| $658M | 1.81% |
+7,669,270
| New | +$651M |
|
9
Cisco
CSCO
$431B
| $614M | 1.69% |
+25,243,617
| New | +$568M |
|
10
Microsoft
MSFT
$3.71T
| $583M | 1.6% |
+16,882,712
| New | +$553M |
|
11
McKesson
MCK
$106B
| $530M | 1.46% |
+4,630,091
| New | +$515M |
|
12
Capital One
COF
$135B
| $517M | 1.42% |
+8,230,409
| New | +$485M |
|
13
Amgen
AMGN
$236B
| $514M | 1.41% |
+5,205,309
| New | +$540M |
|
14
UnitedHealth
UNH
$356B
| $415M | 1.14% |
+6,343,022
| New | +$395M |
|
15
Lear
LEA
$6.64B
| $406M | 1.12% |
+6,708,241
| New | +$387M |
|
16
Truist Financial
TFC
$63.1B
| $395M | 1.09% |
+11,669,053
| New | +$372M |
|
17
State Street
STT
$53.4B
| $392M | 1.08% |
+6,006,314
| New | +$374M |
|
18
Halliburton
HAL
$30.9B
| $380M | 1.05% |
+9,106,982
| New | +$381M |
|
19
Sanofi
SNY
$106B
| $372M | 1.02% |
+7,225,687
| New | +$385M |
|
20
Dover
DOV
$26B
| $355M | 0.98% |
+6,825,599
| New | +$342M |
|
|
FITB
21
Fifth Third Bancorp
FITB
$49.8B
| $349M | 0.96% |
+19,326,728
| New | +$337M |
|
22
Omnicom Group
OMC
$22.7B
| $339M | 0.93% |
+5,397,057
| New | +$331M |
|
23
Cigna
CI
$74.7B
| $338M | 0.93% |
+4,668,845
| New | +$315M |
|
24
Comcast
CMCSA
$94B
| $334M | 0.92% |
+15,951,280
| New | +$329M |
|
|
RDS.A
25
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $332M | 0.91% |
+5,573,451
| New | +$345M |
|
Similar funds
Boston Partners's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Boston Partners, which disclosed 696 positions worth $36.3B. Its ten largest holdings account for 20% of the portfolio.
Its largest position is JPMorgan Chase: 17,616,367 shares worth $930M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, followed by Healthcare and Technology.
- Boston Partners's largest Q2 2013 buy was JPMorgan Chase: 17,616,367 shares worth $930M.
- Boston Partners's ten largest holdings make up 20% of its $36.3B portfolio in Q2 2013.
- Boston Partners disclosed 696 positions in Q2 2013, its first 13F filing on record.
Based on Boston Partners's 13F filing for Q2 2013, filed 1 Aug 2013.